Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

This study has been terminated.
(insufficient enrollment)
Information provided by:
Bristol-Myers Squibb Identifier:
First received: November 14, 2005
Last updated: September 16, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)